Issued & Outstanding: 39,850,242
Conversion of Debentures: 2,715,285
Warrants: 12,318,481
Options: 2,480,000
Fully Diluted: 57,364,008
The new financing will increase the issued and outstanding by
13,333,334 shares and a like number of 2 year warrants priced at C$ 0.40
The immediate cash inflow should be near C$ 4,000,000.
Right?
How far should that take us?
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM